[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,548,996
  • Shares Outstanding, K 284,742
  • Annual Sales, $ 21,840 M
  • Annual Income, $ 1,678 M
  • EBIT $ 2,675 M
  • EBITDA $ 5,137 M
  • 60-Month Beta 0.22
  • Price/Sales 2.00
  • Price/Cash Flow 6.64
  • Price/Book 1.81

Options Overview Details

View History
  • Implied Volatility 28.54% (+1.73%)
  • Historical Volatility 26.63%
  • IV Percentile 53%
  • IV Rank 50.53%
  • IV High 38.88% on 02/06/26
  • IV Low 17.97% on 08/15/25
  • Expected Move (DTE 5) 4.30 (2.88%)
  • Put/Call Vol Ratio 3.63
  • Today's Volume 477
  • Volume Avg (30-Day) 571
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 17,480
  • Open Int (30-Day) 12,517
  • Expected Range 145.13 to 153.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $3.11
  • Number of Estimates 7
  • High Estimate $3.19
  • Low Estimate $3.06
  • Prior Year $3.68
  • Growth Rate Est. (year over year) -15.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
143.00 +4.50%
on 05/05/26
159.95 -6.58%
on 04/17/26
-7.66 (-4.88%)
since 04/08/26
3-Month
143.00 +4.50%
on 05/05/26
187.35 -20.24%
on 02/24/26
-15.68 (-9.50%)
since 02/06/26
52-Week
127.59 +17.12%
on 11/06/25
187.35 -20.24%
on 02/24/26
+17.39 (+13.17%)
since 05/08/25

Most Recent Stories

More News
Becton, Dickinson and Company Q2 Earnings Call Highlights

Becton, Dickinson and Company (NYSE:BDX) reported fiscal second-quarter revenue and adjusted earnings ahead of its internal expectations, while management raised its full-year adjusted earnings outlook...

BDX : 149.43 (-2.50%)
BD’s (NYSE:BDX) Q1 CY2026 Sales Beat Estimates

BD’s (NYSE:BDX) Q1 CY2026 Sales Beat Estimates

BDX : 149.43 (-2.50%)
Becton Dickinson: Fiscal Q2 Earnings Snapshot

Becton Dickinson: Fiscal Q2 Earnings Snapshot

BDX : 149.43 (-2.50%)
BD Appoints Vitor Roque Chief Financial Officer

FRANKLIN LAKES, N.J. , May 7, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Vitor Roque has been named executive...

BDX : 149.43 (-2.50%)
BD Reports Second Quarter Fiscal 2026 Financial Results

FRANKLIN LAKES, N.J. , May 7, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 second...

BDX : 149.43 (-2.50%)
Becton Dickinson's Medical Device Momentum Gets Put to the Test Thursday Morning

Barchart Research What to Expect from BDX Earnings BDX Generated May 6, 2026 Current Price $144.76 EPS Estimate $$2.77 Consensus Rating Moderate Buy Average Move 5.03% Becton Dickinson's Medical Device...

BDX : 149.43 (-2.50%)
BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI

By integrating the BD Pyxis™ Pro and BD Alaris™ platforms, Wellstar Health System is giving clinicians clearer insight, greater accuracy and simple automation, so they can focus on delivering safer,...

BDX : 149.43 (-2.50%)
BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition

Business Group on Health, Cigna Healthcare, and the American Heart Association highlight BD's comprehensive and innovative approach to advancing employee health and well being

BDX : 149.43 (-2.50%)
BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology

With the launch of CentroVena One™, BD brings a first ‑ of ‑ its ‑ kind insertion system to market that simplifies central line placement for clinicians and enhances care in acute...

BDX : 149.43 (-2.50%)
BD Board Declares Dividend

FRANKLIN LAKES, N.J. , April 28, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has...

BDX : 149.43 (-2.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 163.10
2nd Resistance Point 159.19
1st Resistance Point 154.31
Last Price 149.43
1st Support Level 145.52
2nd Support Level 141.61
3rd Support Level 136.73

See More

52-Week High 187.35
Fibonacci 61.8% 164.52
Fibonacci 50% 157.47
Fibonacci 38.2% 150.42
Last Price 149.43
52-Week Low 127.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.